Some of us use bullhorns to tell stories, others use the Internet. We launched the PATH blog to show what happens behind the scenes of our work, from a town crier spreading the word about a new vaccine, to the connections PATH staff members make with people around the world.
Today we feature an interview with PATH’s departing president and CEO, Dr. Christopher J. Elias, as he looks back at his 11 years leading the organization.
To join the conversation on global health issues you care about, subscribe to the PATH blog or visit it on our website.
New drug development program focuses on solutions for neglected diseases. PATH has created a new drug development program through our affiliation with OneWorld Health, a nonprofit research institution headquartered in California. The program will expand the availability of effective, low-cost drugs for some of the world’s most vulnerable people.
PATH marks 20 years in Kenya. Two decades ago we began working to improve health in Kenya, and today the country is home to our largest country program. In December, more than 150 partners and community groups joined us to celebrate our long-standing partnerships and projects in the country.
Alliance seeks lifesaving technologies for mothers. PATH and Merck are collaborating under the Merck for Mothers initiative to evaluate promising technologies that can save women’s lives during pregnancy and childbirth in low-resource settings.
Redesigned ceramic water pot targets low-income households in Cambodia. PATH and our partner, Hydrologic, sought user feedback to update a popular ceramic water pot and boost its appeal for consumers. The updated device, which is already outselling the old design, holds promise for providing more households with safe drinking water and improving health.
Projects advance treatment for diarrheal disease. PATH will lead clinical trials in Bangladesh to evaluate a new formulation of oral rehydration solution (ORS) that treats diarrhea symptoms as well as dehydration. Separately, we are working with the government of Madhya Pradesh, India, to scale up zinc treatment and ORS to control diarrheal disease in ten underserved districts.
Mobile phone-based system will monitor breast milk safety. PATH is partnering with the University of Washington and the Human Milk Banking Association of South Africa to develop a low-cost system that uses cell phones to monitor flash-heated pasteurization of donated breast milk. The project aims to increase the availability of pasteurized breast milk to vulnerable infants.
Partnership explores next-generation pneumococcal vaccine. PATH and Liquidia Technologies are conducting preclinical proof-of-concept studies on a vaccine that uses Liquidia’s particle technology for enhancing efficacy and manufacturing efficiency. The approach could help improve the availability and affordability of pneumococcal vaccines for children in the developing world, where pneumococcal disease hits hardest.
Evidence contributes to HPV vaccine adoption by GAVI Alliance. Results of PATH’s human papillomavirus (HPV) vaccine demonstration projects contributed to the GAVI Alliance’s decision to support HPV vaccines for women and girls in the world’s poorest countries.
PATH’s more than 20 global and country programs now have websites that outline their goals, their work, and their impact. Visit the sites to learn more about our work across diverse regions and topics.
A new issue of Directions in Global Health features PATH’s work to address noncommunicable diseases, health in Kenya, influenza control, gender equity in China, and health services.
A revised series of fact sheets provides overviews of our five areas of focus—emerging and epidemic diseases, health technologies, maternal and child health,
reproductive health, and vaccines and immunization—as well as our work in diarrheal disease, family planning, malaria, and nutrition.
A briefing paper details PATH’s work in Vietnam to develop new clinical guidelines for preventing and treating diarrheal disease, while a fact sheet looks at prioritizing diarrhea prevention and treatment in Malawi.
Two documents describe PATH’s projects to improve household water treatment and storage in Vietnam and support distribution of safe water treatment and storage products via local health workers.
A case study highlights work to develop a total market plan for family planning in Vietnam.
A document helps decision-makers and program planners focus on strategic questions about cervical cancer prioritization and improved cancer prevention.
New brochures feature PATH’s ongoing work in Ethiopia, Kenya, South Africa, and Tanzania.
A fact sheet provides an overview of PATH’s work in Zambia.
A video highlights how PATH is expanding prevention, treatment, care, and support for people living with and affected by HIV/AIDS.
PATH’s Vaccine Resource Library now features resources on polio.
View these new resources and more in our online publications catalog.
Congressional hearing highlights progress against malaria and remaining challenges. Dr. Richard Steketee, science director of the Malaria Control Program at PATH, testified as an expert witness in a US Congressional hearing on the state of malaria control. He and other witnesses emphasized the importance of US leadership to keep up the fight.
PATH talks vaccines with members of Parliament (MPs). PATH staff discussed our work developing vaccines for malaria, diarrheal disease, and meningitis
with nine United Kingdom MPs at a luncheon focusing on the role of UK leadership in advancing new vaccines, including funding their research and development.
GHTC calls for investments in health technologies. Writing in The Hill’s Congress Blog, Global Health Technologies Coalition (GHTC) director Kaitlin Christenson and two GHTC members urged donors to continue funding research and development of lifesaving solutions in the world’s poorest communities. The GHTC is housed at PATH.
